Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
From the article
You might also wanna read
GLP-1 Prescriptions Surge Sevenfold Among Women With PCOS: What to Know About Off-Label Use
GLP-1 drug prescriptions (like Ozempic, Wegovy, Zepbound, Mounjaro) among women with PCOS have surged over sevenfold since 2021, despite the
pcosnutrition.com·2d ago
Systematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefits
A systematic review presented at a medical conference found that GLP-1 agonists (like Ozempic, Wegovy) do not harm male fertility or the mal
mdsc.pe·17d ago
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two observational studies found that GLP-1 receptor agonists (like Ozempic, Wegovy) are associated with reduced breast cancer incidence in w
mdsc.pe·13d ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica
bmj.com·19d ago
GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes
A study published in JAMA Otolaryngology-Head & Neck Surgery found that GLP-1 receptor agonists (RAs) used for type 2 diabetes are associate
mdsc.pe·7d ago
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl
medlink.com·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.